SPIRE Therapeutics, Inc.
PrivateLast Round
Accelerator
Aug 27, 2024
Company Overview
SPIRE Therapeutics, Inc. is a therapeutic devices company that develops noninvasive ultrasound-based neuromodulation technology for the treatment of neurological disorders such as chronic pain and depression.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPIRE Therapeutics, Inc. Comparables
Compare SPIRE Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Attune Neurosciences | 87% | |
| Openwater | 81% | |
| Neurosona | 78% |
SPIRE Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 27, 2024 |
SPIRE Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Accelerator |
| Altitude Lab | Accelerator |
| Wilson Sonsini Goodrich & Rosati | Accelerator |
| Wellcome Trust | Accelerator |
| National Science Foundation | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2024
Led by Altitude Lab with participation from Focused Ultrasound Foundation.
SPIRE Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SPIRE Therapeutics, Inc.'s valuation, stock price, and market status.
Is Spire Therapeutics a public or private company?
Spire Therapeutics is a private company.
What is the current stock price of Spire Therapeutics?
Spire Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Spire Therapeutics worth (valuation)?
Valuation information for Spire Therapeutics is not publicly available.
Can I buy Spire Therapeutics stock?
Spire Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Spire Therapeutics's last funding round?
Spire Therapeutics's most recent funding round was Accelerator on August 27, 2024.
Who are the main investors in Spire Therapeutics?
Key investors in Spire Therapeutics include Altitude Lab.
Will Spire Therapeutics IPO soon?
No public IPO plans have been announced for Spire Therapeutics.
How can I track Spire Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spire Therapeutics's secondary market activity and sign up for updates.